Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +1.05% | -11.93% | -33.79% |
05-15 | Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents | CI |
05-14 | William Blair Upgrades Neuronetics to Outperform From Market Perform | MT |
Sales 2024 * | 79.14M 6.21B | Sales 2025 * | 89.83M 7.04B | Capitalization | 57.6M 4.52B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.12B | Net income 2025 * | -20M -1.57B | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-2.97
x | Employees | 202 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.69% |
Latest transcript on Neuronetics, Inc.
1 day | +1.05% | ||
1 week | -11.93% | ||
1 month | -45.14% | ||
3 months | -36.21% | ||
6 months | -5.42% | ||
Current year | -33.79% |
Managers | Title | Age | Since |
---|---|---|---|
Keith Sullivan
CEO | Chief Executive Officer | 65 | 13/07/20 |
Stephen Furlong
DFI | Director of Finance/CFO | 60 | - |
Cory Anderson
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Cascella
CHM | Chairman | 69 | 31/03/21 |
Sheryl Conley
BRD | Director/Board Member | 63 | 30/09/19 |
Glenn Muir
BRD | Director/Board Member | 65 | 30/06/17 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 1.92 | +1.05% | 130,596 |
30/05/24 | 1.9 | -6.86% | 672,041 |
29/05/24 | 2.04 | -1.92% | 95,720 |
28/05/24 | 2.08 | -4.59% | 67,425 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.79% | 57.6M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- STIM Stock